2020³â~2022³â(ÁÖ)·çÁ¨¿¡½º¾¾¾ÆÀÌ Ã¢¸³±â³äÀÏ 10ÁÖ³â

  • 2022.12

    • ¿¬¼¼´ëÇб³ ÀÇ·á¿ø 3¾ï¿ø »ó´ç ±â¼ú¿ë¿ª°è¾à ¼öÁÖ (Ä¿½ºÅÒ ·»Æ¼¹ÙÀÌ·¯½º °³¹ß»ý»ê)
  • 2022.08

    • "Affinity Bioscience" Çѱ¹°ø½Ä´ë¸®Á¡ ü°á
  • 2021.10

    • ´ë±â¾÷ ±â¼ú¿ë¿ª°è¾à 5¾ï¿ø »ó´ç ¼öÁÖ (Ä¿½ºÅÒ ÆéŸÀ̵幰Áú °³¹ß»ý»ê)
  • 2021.03

    • OA-EDS (ÇüÁúÀüȯ ¿¬°ñ ¼¼Æ÷ÁÖ±â¹Ý HTS ¿¬°ñÀç»ý ¹°Áú ½ºÅ©¸®´× ½Ã½ºÅÛ ¹Ì±¹Æ¯ÇãÃâ¿ø US patent, 17273949
  • 2019³â~2020³âOA-EDS(Osteoarthritis Effective Drug Screening System) ¿øõ±â¼ú ±¹³» ƯÇãµî·Ï

    • 2020.10

      • Mybiosource, Hytest, Abbaltis Çѱ¹´ë¸®Á¡ ü°á
    • 2020.03

      • OA-EDS(Osteoarthritis Effective Drug Screening System) ¿øõ±â¼ú ±¹³» ƯÇãµî·Ï
    • 2019.06

      • Crownbio, Seramun Diagnostica Çѱ¹´ë¸®Á¡ ü°á
    • 2019.01

      • ISO9001(Ç°Áú°æ¿µ½Ã½ºÅÛ), ISO14001(ȯ°æ°æ¿µ½Ã½ºÅÛ) ÀÎÁõ

    2018³âLMO 2µî±Þ½Ã¼³ ±¸Ãà (Custom Lentivirus & Reporter & Stable cell line Á¦ÀÛ¼­ºñ½º°³½Ã)

    • 2018.10

      • 2018³â ±â¼úÆò°¡ ¿ì¼ö±â¾÷ T-5µî±Þ ÀÎÁõ
    • 2018.09

      • OA-EDS(Osteoarthritis Effective Drug Screening System) ¿øõ±â¼ú ƯÇãÃâ¿ø
    • 2018.08

      • Custom Lentivirus & Reporter cell line Á¦ÀÛ ¼­ºñ½º »ç¾÷ °³½Ã
    • 2018.07

      • ·çÁ¨»ý¸í°øÇבּ¸¼Ò "LMO½Ã¼³ 2µî±ÞÇã°¡"
    • 2018.06

      • Çѱ¹»ý»ê±â¼ú¿¬±¸¿ø "¼ö¿ä´ëÀÀ°øµ¿±â¼úÁö¿ø»ç¾÷"¼±Á¤
    • 2018.05

      • ½Å»ç¿Á È®ÀåÀÌÀü(ºÎõ ÃáÀǵ¿ »ïº¸Å×Å©³ëŸ¿ö)

    2016³â ~ 2017³â" 2³â¿¬¼Ó ´ëÇѹα¹ »ê¾÷´ë»ó ¹ÙÀÌ¿ÀºÐ¾ß" ´ë»ó ¼ö»ó

    • 2017.12

      • ¿¬¾ÖÀÎ ºÀ»ç´Ü "´õ ºê¸´Áö"Çà»ç ·çÁ¨½Ã¾ÆÈ­ÀåÇ° ±âºÎÇùÂù
    • 2017.08

      • "LUGENSIA"»óÇ¥µî·Ï ¿Ï·á
      • Çѱ¹»ý»ê±â¼ú¿¬±¸¿ø ÆÄÆ®³Ê±â¾÷ ü°á
    • 2017.03

      • "2017³â ´ëÇѹα¹ »ê¾÷´ë»ó ¹ÙÀÌ¿ÀºÐ¾ß" ´ë»ó ¼ö»ó
    • 2016.12

      • °¡Ãµ´ëÇб³ »êÇÐÇù·Â´Ü °¡Á·È¸»ç MOUü°á
    • 2016.03

      • "2016³â ´ëÇѹα¹ »ê¾÷´ë»ó ¹ÙÀÌ¿ÀºÐ¾ß" ´ë»ó ¼ö»ó
      • ÀÎõ´ëÇб³ »êÇÐÇù·Â´Ü °¡Á·È¸»ç MOUü°á
      • (ÁÖ)½ÃÄ«°í "ÆéŸÀ̵å È­ÀåÇ° 3Á¾" Á¦Ç° °³¹ß °è¾à ¹× "·çÁ¨½Ã¾Æ" ÆÇ¸Å±Ç °è¾à (µ¿³²¾ÆÁö¿ª)
      • MBC µå¶ó¸¶ "¸ó½ºÅÍ" ·çÁ¨½Ã¾Æ È­ÀåÇ° ÇùÂù
    • 2016.02

      • ¸ÅÀÏ°æÁ¦ TV-¼­¿ïÅ©¶ó¿ìµå ÁÖ°ü "Å©¶ó¿ìµå Æݵù¼î" ÇÁ·Î±×·¥ ¹æ¼ÛÃÔ¿µ ¹× ÆݵùÁö¿ø ¼±Á¤
      • KT °è¿­»ç K-Ȩ¼îÇÎ "·çÁ¨½Ã¾Æ" ÀÔÁ¡ (âÁ¶°æÁ¦Å¸¿î ¿ì¼ö ¾ÆÀ̵ð¾î Á¦Ç° À¯ÅëÆÇ·Î Áö¿ø ¼±Á¤)
    • 2016.01

      • ¼­¿ï´ëÇб³ ƯÇã±â¼úÀÇ "¾ÆÅäÇǼº ÇǺο° Ä¡·á¿ë Á¶¼º¹° È¿´É °ËÁõ ¹× ½ÃÁ¦Ç° °³¹ß" À§Å¹, ¼öŹ ¾÷ü ¼±Á¤
      • ºÎõ½Ã ¿ì¼ö±â¾÷ Á¦Ç°¼Ò°³ "·çÁ¨½Ã¾Æ" ¼±Á¤

    2014³â ~ 2015³âÈ­ÀåÇ° ÆéŸÀ̵å¿ø·á ´ë·®»ý»ê½Ã½ºÅÛ ±¸Ãà ¹× ·çÁ¨½Ã¾Æ ÆéŸÀ̵åÈ­ÀåÇ° Ãâ½Ã

    • 2015.10

      • ÆéŸÀ̵å È­ÀåÇ° ·çÁ¨½Ã¾Æ(LUGENCIA¢â) ¾ÚÇà 5Á¾ Ãâ½Ã
      • È­ÀåÇ°
    • 2015.09

      • â¾÷¸ÂÃãÇü°úÁ¦ ¼±Á¤ (âÁ¶°æÁ¦Çõ½Å¼¾ÅÍ Àü´ã ¸àÅä ÁöÁ¤±â¾÷)
    • 2015.01

      • È­ÀåÇ° ÆéŸÀÌµå ¿ø·á »ý»ê
    • 2014.10

      • ´ëÇÑȯ°æ À§Çؼº º¸°Ç°úÇÐȸ Âü°¡
    • 2014.09

      • Çѱ¹¹ß»ý»ý¹°ÇÐȸ Âü°¡
    • 2014.07

      • ±¹³» À¯ÀüÀںм® ±â¾÷µé°ú MOUü°á NGS or Microarray ¼­ºñ½º °³½Ã
      • ±â¾÷ºÎ¼³¿¬±¸¼Ò ÀÎÁõ
    • 2014.02

      • ¹ÙÀÌ¿À±â±â»ê¾÷Àü Âü°¡
    • 2012³â~2013³â´Ü¹éÁúÁ¤Á¦ & ÆéŸÀ̵åÇÕ¼º & À¯ÀüÀÚÇÕ¼º ¼­ºñ½º°³½Ã

      • 2013.07

        • ´Ü¹éÁú È­ÇÐÇü±¤¹ßÇö ÀåÄ¡ °³¹ß ¹× Ãâ½Ã
      • 2013.02

        • °¢ Áö¿ªº° 8°³ ´ë¸®Á¡ ±¸Ãà
      • 2012.11

        • º¥Ã³±â¾÷ÀÎÁõ
      • 2012.10

        • ¿¬±¸°³¹ß Àü´ãºÎ¼­ÀÎÁõ
      • 2012.05

        • ´Ü¹éÁú ºÐ¸® Á¤Á¦ ¹× ÆéŸÀ̵å, À¯ÀüÀÚ ÇÕ¼º ¼­ºñ½º°³½Ã
      • 2012.02

        • (ÁÖ)·çÁ¨¿¡½º¾¾¾ÆÀÌ ¼³¸³
¸Þ´º´Ý±â

°ßÀû¹®ÀÇ

INQUIRY

¾Æ·¡ Ç׸ñ¿¡ ¸Â°Ô Á¤È®È÷ ÀÔ·ÂÇÏ¿© ÁֽʽÿÀ.